VivoSight Dx and Dynamic OCT cleared by the FDA for sale in the US

The FDA have cleared the VivoSight Dx and Dynamic OCT for sale in the US by granting 510(k) K153283.  The VivoSight Dx is a Multi-Beam Optical Coherence Tomography (OCT) system indicated for use in the two-dimensional, cross-sectional, real-time imaging of external tissues of the human body.